Company News

Crown Laboratories To Acquire StriVectin Skin Care

Company creates new premium skin care division.

Author Image

By: Christine Esposito

Editor-in-Chief

Crown Laboratories has entered into a definitive agreement with L Catterton to acquire StriVectin. The transaction is expected to close by mid-September and is subject to regulatory approvals and other customary closing conditions. Terms of the transaction were not disclosed.   Upon completion of the transaction, StriVectin’s products will become part of Crown’s new Premium Skincare Division and will operate as a wholly owned subsidiary of Crown Laboratories. StriVectin President Cori Aleardi...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters